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Understanding Ventilation Strategies for ECMO Patients at a Community Hospital 
Extracorporeal Membrane Oxygenation (commonly abbreviated to ECMO) is a modified form of cardiopulmonary 
bypass utilized in patients with severe yet reversible respiratory and/or cardiac failure (1). The extracorporeal circuit is 
used to directly oxygenate and remove carbon dioxide from the patient’s blood (2). This type of therapy is used as 
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In order to maintain the patient’s lung mechanics and inflation during extracorporeal membrane oxygenation it is 
necessary to incorporate one of the various forms of mechanical ventilation strategies. HFPV is a nonconventional 
form of ventilation which is utilized when PCMV and ECMO parameters are maximized and gas exchange remains 
inadequate, the patient has maintained secretions after frequent bronchoscopies, and the patients lung hypo inflation 
is marked be a compliance of less than or equal to 12cm H2O. HFPV has been shown to work as both an effective 






















This algorithm  was designed  to help the physicians better take care of patients after ECMO cannulation. For 
physicians or nurses who are unfamiliar with the ECMO system, this algorithm gives them step by step instructions  
on how to properly maintain sufficient oxygenation, circulation and lung mechanics. Due to the complexity of some of 
the instructions, nodes were added alongside the text boxes which help the user locate the included explanations. 
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• Data analysis and compilation of all ECMO patients who received High Frequency Percussive Ventilation by VDR 
prior to ECMO cannulation. 
• Data analysis and compilation of all ECMO patients who received High Frequency Percussive Ventilation 
by VDR during ECMO management. 
• Data analysis and compilation of all ECMO patients who received High Frequency Percussive Ventilation by VDR 
prior to and during ECMO management. 
• Comparisons and calculations of survival rates of all ECMO Patients and ECMO patients with VDR 
ECMO Ventilatory Management Algorithm 
 
Node 1: Post ECMO cannulation a pressure volume tool (P/V) assessment should be performed to determine the lower and upper inflections. The PEEP 
should be set to 2 cm H2O above the lower inflection point or higher if there is evidence of premature expiratory limb deflation. The P/V tool should be 
performed every 12 hours or until spontaneous breathing is noted. 
Node 2: PCMV  mode will be utilized and the PIP will be set above the peep to target an exhale tidal volume of 6cc/kg/IBW. 
Node 3: Stable gas exchange is defined as SpO2≥88%/PaO2≥60 torr, and PaCO2/ETCO2≤50 torr 
Node 4: If gas exchange is not adequate the ECMO FIO2 and/or sweep should be increased prior to any ventilator adjustments. Root cause assessments 
should be performed to determine the etiologies of inadequate gas exchange. Ventilator recruitment maneuvers may be attempted by placing the patient 
on 30cm/H2O PEEP for 30 seconds. Ventilator FIO2 should always be 10-20% less than set on ECMO FIO2. 
Node 5: If The reason for inadequate gas exchange is retained secretions, consider bronchoscopy and/or mucokinetic therapy via IPV or manual chest 
percussion. If secretions are voluminous and/or inspissation occurs, consider 24-48 hours of ventilation via HFPV. 
Node 6: If gas exchange is inadequate secondary to poor lung compliance or hypoventilation consider APRV maintaining a Phigh≤32cm/H2O and Thigh≥5 
seconds or extend inspiratory time and inverse ratio PCMV. 
Node 8: Consider HFPV ventilation when the following clinical situations are evident: 
     -ECMO parameters are maximized and gas exchange remains inadequate 
     -Frequent bronchoscopies and evidence of retained secretions 
     -Lung hypoinflation marked by a compliance of ≤12cm/H2O 
Attempt to maintain the VDR PIP/PEEP parameters as low as possible, maintaining a minimum driving pressure ≥15cm/H2O. 
 
ECMO Ventilatory Management Algorithm 
 
• 42 patients were cannulated with ECMO at Lehigh Valley Health Network (LVHN) since January of 2013. All 
patients’ data was analyzed and a comprehensive ECMO database was created. All of these patients were also 
placed on mechanical ventilation during their treatment with ECMO. 21 of these 42 patients were treated with high 
frequency percussive ventilation (HFPV) and various aspects of their data were analyzed to better understand the 
efficacy of the VDR ventilator. Patient age, etiology, reason for use of HFPV ventilation strategy, RESP score 
(pulmonary score developed by The Australian and New Zealand Intensive Care Research Centre), and current 
status of patient were all taken into consideration. By comparing these various pieces of data the effectiveness of 
the HFPV strategy was determined. 
• HFPV is a nonconventional form of ventilation which is utilized when PCMV and ECMO parameters are maximized 
and gas exchange remains inadequate, the patient has maintained secretions after frequent bronchoscopies, and 
the patients lung hypo inflation is marked be a compliance of less than or equal to 12cm H2O. HFPV has been 
shown to work as both an effective ventilator and a powerful mucokinetic. By keeping the patients lungs 
operational during ECMO management, the patient is more quickly weaned off of ECMO due to maintained lung 
compliance, elasticity, and ventilation. To further understand the effectiveness and uses of HFPV employed by the 
VDR ventilator, the data of 40 patients who were placed on ECMO in combination with either high frequency 
percussive ventilation or pressure control mandatory ventilation was analyzed.  
• The average survival rate recorded in the ELSO database (Extracorporeal Life Support Organization) is 
57%. Since the initiation of the ECMO program at the Lehigh Valley Health Network (LVHN) 42 patients 
have undergone ECMO management and 28 of the 42 patients survived (68.3% survival). One of the 
patients is currently undergoing ECMO management and therefore this patient’s status was not factored 
into the survival rate. Of the various ventilation strategies used in combination with ECMO management, 
HFPV administered by VDR was used on 21 patients at some point during their management, prior to 
cannulation, during ECMO management, or both. Of the 21 total HFPV administered by VDR patients, 20 
of them have been decannulated (taken off of ECMO) and 14 of them survived, giving these patients a 
survival rate of 70%. The average age of these HFPV administered by VDR patients was recorded at 48.04 
years and included 11 female patients and 10 male patients. The most common etiologies of these HFPV 
administered by VDR ECMO patients included H1N1 (7), Pneumonia (4), and Aspiration (6). 
 
Since January of 2013 Lehigh Valley Health network has utilized ECMO management on a total of 42 patients with 
Acute Respiratory Distress Syndrome (ARDS). Lehigh Valley Health network has maintained a survival rate of over 
68.3%, which markedly higher than the national average recorded by the ELSO database of 57%. By utilizing various 
ventilatory strategies (VDR), patients who were not being oxygenated properly using PCMV or were otherwise unstable 
were more successfully managed. By studying the success rate of High Frequency Percussive Ventilation and the VDR 
ventilator we hoped to show that not only is this mode of ventilation capable of maintaining lung mechanics during 
ECMO management, but that it could have improved patient outcomes for patients with whom PCMV is not sufficient. 
 
Of the 42 ECMO patients, HFPV with VDR was utilized on a total of 21 patients. These patients were ventilated using 
HFPV with VDR for various reasons including gas exchange, air leaks, lung recruitment, and sustained secretions. The 
ECMO patients with whom HFPV was utilized ended up with a survival rate of over 70%. The patients who were 
ventilated using conventional ventilation (PCMV) had a slightly lower survival rate of 66.7% resulting with an overall 
survival rate of 68.3%. Looking at this data it is clear that HFPV is not only a legitimate ventilation strategy, but can 
have extremely positive outcomes on patients who were not responding well to conventional ventilation or were put 
on HFPV due to other factors (see tables 1-3). We believe that among other factors, LVHN’s utilization of HFPV and the 
VDR ventilator contribute greatly to the much higher than average survival rates of our ECMO patients.  
 
